Contributor Page
Akin Gump Strauss Hauer & Feld LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 310 229 1000
Fax: +1 310 229 1001
1999 Avenue of the Stars Suite 600
Los Angeles
CA 90067-6022
United States
By Anne Borkovic, Jonathan Poling, Wynn Segall, Andrew R. Schlossberg, Jennifer M. Thunem
On August 8, OFAC issued Findings of Violation to two U.S. companies in relation to administrative subpoenas with follow-up responses deemed
By Wynn Segall, Nnedinma Ifudu Nweke, Melissa Schwartz, Dallas Woodrum, Andrew R. Schlossberg
The U.S. Department of State and the U.S. Department of the Treasury, Office of Foreign Assets Control (OFAC) have imposed three new sanctions on Russia
By Hamish Lal, Josephine Kaiding
International Construction Arbitration has received a shock. Consistent with the leading textbooks
By Donald R. Pongrace, Pratik Shah, Allison Binney, Z.W. Julius Chen, Merrill C. Godfrey
On Friday, August 9, 2019, in Brackeen v. Bernhardt, No. 18-11479, the U.S. Court of Appeals for the 5th Circuit declared that the Indian Child Welfare Act (ICWA) and its implementing federal regulations ("the Final Rule")...
By Susan Lent, Natasha Kohne, Diana Schaffner, Galen Roehl
Based on recent activity in Washington, D.C., it is possible that we will see developments this fall related to autonomous vehicles (AV) policy.
By Robert K. Huffman, Angela B. Styles, Scott M. Heimberg, Thomas P. McLish, Kevin Wolf, Thomas McCarthy, Shiva Aminian, Chris Chamberlain, Christopher Treanor
On August 7, the DOD, GSA, and NASA released a prepublication version of an Interim Final Rule implementing paragraph (a)(1)(A) of § 889 of the 2019 NDAA.
By Susan Lent, Natasha Kohne, Diana Schaffner, Galen Roehl
Recent events in Washington, D.C., suggest that we may see developments this fall with regard to autonomous vehicles (AV)
By Matthew Wetzel, Blair M. Cantfil, Marlee Gallant, Mallory Jones
On July 18, 2019, the CMS and the CMMI published a proposal to implement a new mandatory Medicare payment model in select geographic areas—the Radiation Oncology (RO) Model.
By Jan-Paul Bruynes, Jason M. Daniel
On August 10, 2017, staff of the U.S. CFTC issued No-Action Letter 17-371, which provides relief with respect to the position limit disaggregation notice filing requirements under Rule 150.4(c)2...
By Benjamin Harris, Jeffrey Mutterperl
IAM has published "CAFC creates blueprint for early stage challenges to claims brought under doctrine of equivalents,"
By John Jonas, Martha M. Kendrick, M. Todd Tuten, Lauren O'Brien, Eli Z. Tomar
Recent months have seen a flurry of activity in Congress on prescription drug pricing and surprise medical bills as lawmakers seek to address rising consumer health care costs.
By Kevin Wolf, Shiva Aminian, Chris Chamberlain, Nathaniel Edwards
The Department of Commerce has announced that it plans to eliminate License Exception CIV (civil end-users) from the Export Administration Regulations (EAR).
By Akin Gump Strauss Hauer & Feld LLP
In this episode, demonstrating solutions in fund formation and negotiation, Akin Gump investment management lawyers Jim Deeken and Gechi Tesic perform a mock negotiation between a private equity firm and...
By Natasha Kohne, Michelle Reed, Jenny Arlington, Rachel Kurzweil, Sahar Abas, Diana Schaffner
Data protection authorities (DPAs) in the European Union (EU) continue to scrutinize practices in the adtech sector for compliance with the EU's
By Nathan A. Brown, Caroline Wolverton, Christin Helms Carey, Howard R. Sklamberg, Eli Z. Tomar, Sudhana Bajracharya
On August 1, 2019, the U.S. District Court for the District of Columbia affirmed the U.S. Food and Drug Administration's (FDA's) decision to exclude the bulk drug substance vasopressin
Contributor's Topics